What: Oncothyreon is down 30% at 1:30 p.m. EST after announcing updated data from its ongoing trials testing ONT-380 in patients with breast cancer yesterday. So what: From the stock move, you'd think ...

A barrage of post-shutdown data this week has left economists with more questions than answers about the state of the U.S. economy. Unemployment rose to a four-year high in November, inflation ...

Despite a general sense that engaging in big data analytics is important for success in the current health information technology landscape, 51% of organizations do not truly know what kind of data-or ...